Mario Vaccaro Selected Research

Mario Vaccaro Research Topics

Disease

6	Skin Diseases (Skin Disease) 01/2022 - 03/2009
5	Wounds and Injuries (Trauma) 10/2021 - 05/2008
5	Vitiligo 10/2021 - 06/2015
5	Asthma (Bronchial Asthma) 01/2020 - 05/2008
4	Inflammation (Inflammations) 10/2021 - 09/2011
4	Chronic Urticaria 11/2020 - 03/2016
4	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2020 - 09/2016
3	Infections 10/2022 - 06/2011
3	Cicatrix (Scar) 03/2022 - 10/2009
3	Stomatitis 02/2022 - 06/2020
3	Burns 01/2018 - 05/2008
2	Immune System Diseases (Immune Disorders) 10/2022 - 01/2013
2	Fibrosis (Cirrhosis) 03/2022 - 01/2018
2	Acne Vulgaris 03/2022 - 01/2004
2	Warts (Wart) 12/2021 - 09/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020 - 01/2018
2	Telangiectasis (Telangiectasia) 11/2020 - 07/2016
2	Urticaria (Hives) 01/2020 - 01/2018
2	Arthritis (Polyarthritis) 01/2019 - 09/2011
2	Erythema 01/2018 - 07/2013
2	Contact Dermatitis (Eczema, Contact) 01/2018 - 04/2009
2	Alopecia (Baldness) 09/2017 - 03/2015
2	Necrosis 03/2017 - 01/2002
2	Dermatitis 03/2017 - 01/2014
2	Actinic Keratosis 01/2017 - 11/2009
2	Ulcer 12/2014 - 05/2014
2	Allergic Contact Dermatitis 01/2014 - 05/2008
1	Cytokine Release Syndrome 10/2022
1	Pityriasis 10/2022
1	Hidradenitis Suppurativa 03/2022
1	Condylomata Acuminata (Genital Wart) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Ischemia 10/2021
1	Hypoxia (Hypoxemia) 10/2021
1	Disease Progression 10/2021
1	Blister (Bulla) 11/2020
1	Pityriasis Rosea 11/2020
1	Neoplasms (Cancer) 04/2020
1	Glioblastoma (Glioblastoma Multiforme) 04/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2019
1	Acne Conglobata 09/2018

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 10/2022 - 09/2011
4	Omalizumab (Xolair)FDA Link 11/2020 - 03/2016
4	Proteins (Proteins, Gene)FDA Link 12/2013 - 11/2004
3	InterleukinsIBA 10/2022 - 06/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 08/2017
3	PolydeoxyribonucleotidesIBA 10/2021 - 05/2008
3	CollagenIBA 10/2021 - 01/2019
3	Biological ProductsIBA 10/2021 - 02/2004
3	caryophylleneIBA 06/2020 - 01/2019
3	Imiquimod (Aldara)FDA LinkGeneric 02/2020 - 11/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018 - 05/2008
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018 - 12/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2017 - 11/2002
3	AntigensIBA 01/2013 - 01/2002
2	ChemokinesIBA 10/2022 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2017
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2021 - 06/2021
2	CateninsIBA 06/2021 - 02/2020
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2020 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 02/2020 - 03/2017
2	Petrolatum (Vaseline)FDA Link 02/2020 - 03/2017
2	Immunoglobulin E (IgE)IBA 01/2020 - 03/2016
2	Histamine Antagonists (Antihistamines)IBA 01/2020 - 03/2016
2	Malondialdehyde (Propanedial)IBA 02/2018 - 01/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2017 - 05/2008
2	Interleukin-23 (Interleukin 23)IBA 03/2017 - 06/2015
2	EnzymesIBA 09/2016 - 06/2015
2	AutoantigensIBA 06/2011 - 11/2004
2	AntibodiesIBA 11/2004 - 01/2002
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 10/2022
1	InterferonsIBA 10/2022
1	LigandsIBA 10/2022
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2022
1	Interleukin-17 (Interleukin 17)IBA 10/2022
1	Janus KinasesIBA 10/2022
1	MicroRNAs (MicroRNA)IBA 03/2022
1	AntioxidantsIBA 02/2022
1	flavocoxidIBA 02/2022
1	NivolumabIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2020
1	cemiplimabIBA 11/2020
1	Peptides (Polypeptides)IBA 11/2020
1	CB2 Cannabinoid ReceptorIBA 04/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2020
1	dupilumabIBA 01/2020
1	pazopanib FDA Link 11/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	cibinetideIBA 02/2018

Therapy/Procedure

9	Photochemotherapy (Photodynamic Therapy) 01/2022 - 03/2009
9	Therapeutics 01/2022 - 12/2014
2	Radiotherapy 06/2021 - 12/2016
1	Drug Therapy (Chemotherapy) 06/2021